Skip to main content
Premium Trial:

Request an Annual Quote

Bruker MALDI Tissuetyper, MALDI PharmaPulse, and Mycobacteria Library 3.0

Bruker this week launched three new products at the American Society for Mass Spectrometry and American Society for Microbiology conferences.

The Bruker Maldi Tissuetyper application on Bruker rapifleX MALDI-TOF mass spec system is designed for MALDI imaging anatomical pathology research. The solution works up to 20 times faster than traditional MALDI-TOF systems, using Bruker's proprietary smartbeam 3D laser, the company said. This laser is synchronized with the movement of the MALDI target stage, and has a repetition rate of 10 kHz, enabling higher throughput where researchers have dramatically increased flexibility in pixel size or target tissue size. Depending on sample size, typical tissue sections can now be imaged in approximately 30 minutes, while mass spec images from small tissue biopsies are available in a few minutes, the company said.

Meantime, Bruker's MALDI PharmaPulse solution combines Bruker's MALDI-TOF systems with high-throughput screening robotics and automation software from HighRes Biosolutions to help pharmaceutical, biotech, and contract research customers accelerate drug discovery and development.

Finally, Bruker released the 3.0 expansion of its Mycobacteria Library for research use only on the MALDI Biotyper system. The new library now includes 149 different species, enabling significantly improved rapid and accurate identification of almost all described Mycobacteria species, the company said.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.